ArticleThe journal of allergy and clinical immunology. Global2025

Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosis.

Pedro A Lamothe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.